Ulf Bremberg

Ulf Bremberg is a PhD in medicinal chemistry with over 20 years of experience in the pharmaceutical industry. For the past six years, he has dedicated himself to enabling and coordinating psychedelic research, with the goal of laying the foundation for a future implementation of psychedelic-assisted therapy in the healthcare system. Ulf runs the company Osmond Labs (formerly Humankind Labs) and is currently working to coordinate Psypal – a large-scale European clinical trial on psilocybin that is the first of its kind. The study is fully funded by Horizon Europe, the EU's leading research and innovation program.